EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued list…
Category: News
Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2024 will be released before mar…
Introducing RevEngage: Patient Communication Simplified
SAN DIEGO–(BUSINESS WIRE)–RevolutionEHR, the leading provider of optometry practice management software, has released its robust new patient engagement solution, RevEngage.
Alivi Health Unveils Innovative Vision Program, Setting a New Standard in Healthcare Offerings
MIAMI–(BUSINESS WIRE)–Alivi Health, a leading provider of transportation, card-based, and specialty benefits, unveils a new Vision Program, a groundbreaking service designed to elevate medical centers’ offerings and enhance member satisfaction. The c…
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue® Eye Care Recycling programs have colle…
Ocular Microbiome May Be Dry Eye Culprit
Researchers are trying to understand what role bacteria play in various eye conditions. Medscape Medical News
Pantheon Vision Announces Two Successful Pre-Submission Meetings With the FDA
BALTIMORE–(BUSINESS WIRE)–Pantheon Vision, a pre-clinical stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, announced today the completion of two successful and productive Pre-Submission meetings w…
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase from the first quarter of 202…
Glaukos Announces the Release of its 2023 Sustainability Report
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
CDC Investigating Reactions Linked to Counterfeit ‘Botox’
Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism. MDedge News
Can Thyroid Dysfunction Cause Hormonal Imbalance?
When to suspect that thyroid dysfunction is responsible for a hormonal imbalance, and how to determine whether it is the cause. American Thyroid Association
Increased Retinopathy Risk Seen With GLP-1RAs for Diabetes
But diabetes-related eye complication risks were reduced with SGLT2 inhibitors and insulin. Medscape News UK
Are You Ready for AI to Be a Better Doctor Than You?
Study after study show AI outperforming MDs in all areas. How should all-too-human physicians — who have trained for years to be good at what they do — feel about this? Medscape Medical News
Both Parotid and Labial Gland Biopsies Can Diagnose SjS
Although largely similar, some important histopathologic differences were seen in the biopsies of the labial and parotid salivary glands in individuals with suspected SjS. Medscape Medical News
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first…
iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging
NEW YORK–(BUSINESS WIRE)– #AI–iPredictTM glaucoma detection model provides a fully automated detection report for glaucoma which can be implemented in the primary care settings for screening and detection of early-stage glaucoma. The full US patent …
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AMLX–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with management and Fumihiko Urano, MD, PhD, Principal Investigator of the HELI…
拨康视云（Cloudbreak Pharma） 最新调查结果凸显眼疾负担，彰顯非手术治疗选项对于被低估和未充分治疗的翼状胬肉眼疾的重要性
加州尔湾–(BUSINESS WIRE)–(美国商业资讯)– 拨康视云是一家临床阶段的生物技术公司，致力于开发治疗常见但治療方案甚少的眼科疾病的药物。該公司在波士顿举行的年度ASCRS会议上分享了一项由公司支持的调查数据，该调查彰顯了翼状胬肉的患者负担。翼状胬肉是一种眼部疾病，通常被称为“冲浪者眼”，可能是暴露于高水平紫外线辐射環境而引起的。1 这项横断面调查显示，50％的受访者报告称翼状胬肉对他们的生活产生了相当大的影响，經常干扰他们进行日常活动的能力。2超过一半的受访患者还表示环境因素，如…
New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease
IRVINE, Calif.–(BUSINESS WIRE)–Cloudbreak Pharma, a clinical stage biotechnology company developing ophthalmic drugs for common eye diseases with few treatment options, shared new data from a company-supported survey highlighting the patient burden o…